RecruitingNot applicableNCT06368388

Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force

Studying Pituitary stalk interruption syndrome

Last synced from ClinicalTrials.gov March 21, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Universitaire Ziekenhuizen KU Leuven
Principal Investigator: Jolien Onsea, PhD
Intervention: Prospective data collection(other)
Eligibility: All sexes
Timeline: 2021 – 2024

Study locations (1)

University Hospitals Leuven, Leuven, Belgium

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06368388 on ClinicalTrials.gov

Other trials for Pituitary stalk interruption syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT04448951
Immune Homeostasis in Sepsis and Septic Shock
Charles University, Czech Republic

See all trials for Pituitary stalk interruption syndrome →

← Back to all trials